Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$225.52 - $304.06 $190,338 - $256,626
-844 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$235.95 - $293.05 $9,673 - $12,015
-41 Reduced 4.63%
844 $220,000
Q4 2020

Feb 12, 2021

SELL
$215.97 - $265.89 $55,720 - $68,599
-258 Reduced 22.57%
885 $226,000
Q3 2020

Nov 12, 2020

SELL
$192.55 - $236.59 $170,406 - $209,382
-885 Reduced 43.64%
1,143 $270,000
Q2 2020

Aug 13, 2020

SELL
$159.17 - $224.73 $107,758 - $152,142
-677 Reduced 25.03%
2,028 $394,000
Q1 2020

May 12, 2020

SELL
$130.01 - $216.44 $192,154 - $319,898
-1,478 Reduced 35.33%
2,705 $448,000
Q4 2019

Feb 11, 2020

SELL
$144.81 - $186.0 $131,342 - $168,702
-907 Reduced 17.82%
4,183 $716,000
Q3 2019

Nov 12, 2019

SELL
$117.35 - $167.95 $172,739 - $247,222
-1,472 Reduced 22.43%
5,090 $839,000
Q2 2019

Aug 14, 2019

SELL
$82.13 - $120.73 $4,599 - $6,760
-56 Reduced 0.85%
6,562 $783,000
Q1 2019

May 15, 2019

BUY
$72.44 - $101.87 $169,654 - $238,579
2,342 Added 54.77%
6,618 $629,000
Q4 2018

Feb 13, 2019

BUY
$73.27 - $105.19 $53,706 - $77,104
733 Added 20.69%
4,276 $339,000
Q3 2018

Nov 13, 2018

SELL
$81.43 - $108.13 $2.8 Million - $3.72 Million
-34,360 Reduced 90.65%
3,543 $375,000
Q2 2018

Aug 14, 2018

SELL
$83.27 - $101.93 $2.19 Million - $2.68 Million
-26,302 Reduced 40.97%
37,903 $3.25 Million
Q1 2018

May 15, 2018

BUY
$68.49 - $87.2 $433,952 - $552,499
6,336 Added 10.95%
64,205 $5.57 Million
Q4 2017

Feb 08, 2018

SELL
$55.67 - $71.8 $576,908 - $744,063
-10,363 Reduced 15.19%
57,869 $3.99 Million
Q3 2017

Nov 14, 2017

BUY
$49.68 - $59.46 $3.39 Million - $4.06 Million
68,232
68,232 $3.76 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.